启明医疗-B(02500)拟1500万美元出售被投资公司Valgen Holding Corporation约1.05%股份

智通财经2025-12-29

智通财经APP讯，启明医疗-B(02500)发布公告，于2025年12月29日，卖方启明医疗(香港)有限公司与买方Broncus China Holding Corporation订立股份转让协议，卖方同意出售而买方同意购买销售股份，代价为1500万美元，占被投资公司Valgen Holding Corporation于本公告日期已发行股份总数(按全面摊薄及已转换基准)约1.05%。被投资公司为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2595780558?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-29 20:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595780558","market":"us","top_or_hot":-1,"title":"启明医疗-B(02500)拟1500万美元出售被投资公司Valgen Holding Corporation约1.05%股份","media":"智通财经","content":"<div>\n<p>智通财经APP讯，启明医疗-B(02500)发布公告，于2025年12月29日，卖方启明医疗(香港)有限公司与买方Broncus China Holding Corporation订立股份转让协议，卖方同意出售而买方同意购买销售股份，代价为1500万美元，占被投资公司Valgen Holding Corporation于本公告日期已发行股份总数(按全面摊薄及已转换基准)约1.05%。被投资公司为...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1386747.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>启明医疗-B(02500)拟1500万美元出售被投资公司Valgen Holding Corporation约1.05%股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n启明医疗-B(02500)拟1500万美元出售被投资公司Valgen Holding Corporation约1.05%股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-29 20:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1386747.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，启明医疗-B(02500)发布公告，于2025年12月29日，卖方启明医疗(香港)有限公司与买方Broncus China Holding Corporation订立股份转让协议，卖方同意出售而买方同意购买销售股份，代价为1500万美元，占被投资公司Valgen Holding Corporation于本公告日期已发行股份总数(按全面摊薄及已转换基准)约1.05%。被投资公司为...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1386747.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1386747.html","article_id":"2595780558","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595780558","pubTimestamp":1767011973,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，启明医疗-B 发布公告，于2025年12月29日，卖方启明医疗(香港)有限公司与买方Broncus China Holding Corporation订立股份转让协议，卖方同意出售而买方同意购买销售股份，代价为1500万美元，占被投资公司Valgen Holding Corporation于本公告日期已发行股份总数约1.05%。被投资公司为根据开曼群岛法律注册成立及存续的获豁免公司。其主要从事为二尖瓣反流、三尖瓣反流等病变提供系统性解决方案。董事会认为审慎的资本管理有利于确保本集团的可持续发展及加强股东回报。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1574":"生物医药B类股","BK1100":"医疗保健设备","BK1583":"高瓴概念","02500":"启明医疗-B"},"translate_title":"Qiming Medical-B (02500) plans to sell approximately 1.05% stake in the invested company Valgen Holding Corporation for US $15 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02500":1.5},"content_text":"智通财经APP讯，启明医疗-B(02500)发布公告，于2025年12月29日，卖方启明医疗(香港)有限公司与买方Broncus China Holding Corporation订立股份转让协议，卖方同意出售而买方同意购买销售股份，代价为1500万美元，占被投资公司Valgen Holding Corporation于本公告日期已发行股份总数(按全面摊薄及已转换基准)约1.05%。被投资公司为根据开曼群岛法律注册成立及存续的获豁免公司。其主要从事为二尖瓣反流、三尖瓣反流等病变提供系统性解决方案。为优先重新分配资源以发展其核心产品及支持其长期业务增长，本公司持续精简其投资组合及专注于其主要业务营运。作为被投资公司的少数财务投资者，出售事项为本集团变现其投资的适当机会：透过剥离非核心业务投资，本集团将能够加强其现金流，改善其营运资金状况，提升整体财务灵活性，并促进资源重新分配至其核心业务。董事会认为审慎的资本管理(包括本次出售事项)有利于确保本集团的可持续发展及加强股东回报。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2595780558","isCrawlerRequest":true}